The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Filgrastim Injection Market Research Report 2025
Synopsis
Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
The global Filgrastim Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Filgrastim Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Filgrastim Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Filgrastim Injection include Accord Healthcare, Teva Pharmaceuticals, Pfizer, Amgen Inc and Novartis AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Filgrastim Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgrastim Injection.
Report Scope
The Filgrastim Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Filgrastim Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Filgrastim Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG
Segment by Type
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Filgrastim Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
The global Filgrastim Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Filgrastim Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Filgrastim Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Filgrastim Injection include Accord Healthcare, Teva Pharmaceuticals, Pfizer, Amgen Inc and Novartis AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Filgrastim Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgrastim Injection.
Report Scope
The Filgrastim Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Filgrastim Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Filgrastim Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG
Segment by Type
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Filgrastim Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Filgrastim Injection Market Overview
1.1 Product Overview and Scope of Filgrastim Injection
1.2 Filgrastim Injection Segment by Type
1.2.1 Global Filgrastim Injection Market Value Comparison by Type (2024-2030)
1.2.2 300mcg/mL (vial)
1.2.3 480mcg/1.6 mL (vial)
1.2.4 300mcg/0.5mL (Prefilled Syringe)
1.2.5 480mcg/0.8mL (Prefilled Syringe)
1.3 Filgrastim Injection Segment by Application
1.3.1 Global Filgrastim Injection Market Value by Application: (2024-2030)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Filgrastim Injection Market Size Estimates and Forecasts
1.4.1 Global Filgrastim Injection Revenue 2019-2030
1.4.2 Global Filgrastim Injection Sales 2019-2030
1.4.3 Global Filgrastim Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Filgrastim Injection Market Competition by Manufacturers
2.1 Global Filgrastim Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Filgrastim Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Filgrastim Injection Average Price by Manufacturers (2019-2024)
2.4 Global Filgrastim Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Filgrastim Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Filgrastim Injection, Product Type & Application
2.7 Filgrastim Injection Market Competitive Situation and Trends
2.7.1 Filgrastim Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Filgrastim Injection Players Market Share by Revenue
2.7.3 Global Filgrastim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Filgrastim Injection Retrospective Market Scenario by Region
3.1 Global Filgrastim Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Filgrastim Injection Global Filgrastim Injection Sales by Region: 2019-2030
3.2.1 Global Filgrastim Injection Sales by Region: 2019-2024
3.2.2 Global Filgrastim Injection Sales by Region: 2025-2030
3.3 Global Filgrastim Injection Global Filgrastim Injection Revenue by Region: 2019-2030
3.3.1 Global Filgrastim Injection Revenue by Region: 2019-2024
3.3.2 Global Filgrastim Injection Revenue by Region: 2025-2030
3.4 North America Filgrastim Injection Market Facts & Figures by Country
3.4.1 North America Filgrastim Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Filgrastim Injection Sales by Country (2019-2030)
3.4.3 North America Filgrastim Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Filgrastim Injection Market Facts & Figures by Country
3.5.1 Europe Filgrastim Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Filgrastim Injection Sales by Country (2019-2030)
3.5.3 Europe Filgrastim Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Filgrastim Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Filgrastim Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Filgrastim Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Filgrastim Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Filgrastim Injection Market Facts & Figures by Country
3.7.1 Latin America Filgrastim Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Filgrastim Injection Sales by Country (2019-2030)
3.7.3 Latin America Filgrastim Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Filgrastim Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Filgrastim Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Filgrastim Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Filgrastim Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Filgrastim Injection Sales by Type (2019-2030)
4.1.1 Global Filgrastim Injection Sales by Type (2019-2024)
4.1.2 Global Filgrastim Injection Sales by Type (2025-2030)
4.1.3 Global Filgrastim Injection Sales Market Share by Type (2019-2030)
4.2 Global Filgrastim Injection Revenue by Type (2019-2030)
4.2.1 Global Filgrastim Injection Revenue by Type (2019-2024)
4.2.2 Global Filgrastim Injection Revenue by Type (2025-2030)
4.2.3 Global Filgrastim Injection Revenue Market Share by Type (2019-2030)
4.3 Global Filgrastim Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Filgrastim Injection Sales by Application (2019-2030)
5.1.1 Global Filgrastim Injection Sales by Application (2019-2024)
5.1.2 Global Filgrastim Injection Sales by Application (2025-2030)
5.1.3 Global Filgrastim Injection Sales Market Share by Application (2019-2030)
5.2 Global Filgrastim Injection Revenue by Application (2019-2030)
5.2.1 Global Filgrastim Injection Revenue by Application (2019-2024)
5.2.2 Global Filgrastim Injection Revenue by Application (2025-2030)
5.2.3 Global Filgrastim Injection Revenue Market Share by Application (2019-2030)
5.3 Global Filgrastim Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Accord Healthcare Filgrastim Injection Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Filgrastim Injection Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Filgrastim Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Filgrastim Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Amgen Inc
6.4.1 Amgen Inc Corporation Information
6.4.2 Amgen Inc Description and Business Overview
6.4.3 Amgen Inc Filgrastim Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Inc Filgrastim Injection Product Portfolio
6.4.5 Amgen Inc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Filgrastim Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis AG Filgrastim Injection Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Filgrastim Injection Industry Chain Analysis
7.2 Filgrastim Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Filgrastim Injection Production Mode & Process
7.4 Filgrastim Injection Sales and Marketing
7.4.1 Filgrastim Injection Sales Channels
7.4.2 Filgrastim Injection Distributors
7.5 Filgrastim Injection Customers
8 Filgrastim Injection Market Dynamics
8.1 Filgrastim Injection Industry Trends
8.2 Filgrastim Injection Market Drivers
8.3 Filgrastim Injection Market Challenges
8.4 Filgrastim Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Filgrastim Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Filgrastim Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Filgrastim Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Filgrastim Injection Sales (KL) of Key Manufacturers (2019-2024)
Table 5. Global Filgrastim Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Filgrastim Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Filgrastim Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Filgrastim Injection Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Filgrastim Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Filgrastim Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Filgrastim Injection, Product Type & Application
Table 12. Global Key Manufacturers of Filgrastim Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Filgrastim Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Filgrastim Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Filgrastim Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Filgrastim Injection Sales by Region (2019-2024) & (KL)
Table 18. Global Filgrastim Injection Sales Market Share by Region (2019-2024)
Table 19. Global Filgrastim Injection Sales by Region (2025-2030) & (KL)
Table 20. Global Filgrastim Injection Sales Market Share by Region (2025-2030)
Table 21. Global Filgrastim Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Filgrastim Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Filgrastim Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Filgrastim Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Filgrastim Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Filgrastim Injection Sales by Country (2019-2024) & (KL)
Table 27. North America Filgrastim Injection Sales by Country (2025-2030) & (KL)
Table 28. North America Filgrastim Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Filgrastim Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Filgrastim Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Filgrastim Injection Sales by Country (2019-2024) & (KL)
Table 32. Europe Filgrastim Injection Sales by Country (2025-2030) & (KL)
Table 33. Europe Filgrastim Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Filgrastim Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Filgrastim Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Filgrastim Injection Sales by Region (2019-2024) & (KL)
Table 37. Asia Pacific Filgrastim Injection Sales by Region (2025-2030) & (KL)
Table 38. Asia Pacific Filgrastim Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Filgrastim Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Filgrastim Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Filgrastim Injection Sales by Country (2019-2024) & (KL)
Table 42. Latin America Filgrastim Injection Sales by Country (2025-2030) & (KL)
Table 43. Latin America Filgrastim Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Filgrastim Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Filgrastim Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Filgrastim Injection Sales by Country (2019-2024) & (KL)
Table 47. Middle East & Africa Filgrastim Injection Sales by Country (2025-2030) & (KL)
Table 48. Middle East & Africa Filgrastim Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Filgrastim Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Filgrastim Injection Sales (KL) by Type (2019-2024)
Table 51. Global Filgrastim Injection Sales (KL) by Type (2025-2030)
Table 52. Global Filgrastim Injection Sales Market Share by Type (2019-2024)
Table 53. Global Filgrastim Injection Sales Market Share by Type (2025-2030)
Table 54. Global Filgrastim Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Filgrastim Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Filgrastim Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Filgrastim Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Filgrastim Injection Price (US$/L) by Type (2019-2024)
Table 59. Global Filgrastim Injection Price (US$/L) by Type (2025-2030)
Table 60. Global Filgrastim Injection Sales (KL) by Application (2019-2024)
Table 61. Global Filgrastim Injection Sales (KL) by Application (2025-2030)
Table 62. Global Filgrastim Injection Sales Market Share by Application (2019-2024)
Table 63. Global Filgrastim Injection Sales Market Share by Application (2025-2030)
Table 64. Global Filgrastim Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Filgrastim Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Filgrastim Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Filgrastim Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Filgrastim Injection Price (US$/L) by Application (2019-2024)
Table 69. Global Filgrastim Injection Price (US$/L) by Application (2025-2030)
Table 70. Accord Healthcare Corporation Information
Table 71. Accord Healthcare Description and Business Overview
Table 72. Accord Healthcare Filgrastim Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Accord Healthcare Filgrastim Injection Product
Table 74. Accord Healthcare Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Filgrastim Injection Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Filgrastim Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Pfizer Filgrastim Injection Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Amgen Inc Corporation Information
Table 86. Amgen Inc Description and Business Overview
Table 87. Amgen Inc Filgrastim Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Amgen Inc Filgrastim Injection Product
Table 89. Amgen Inc Recent Developments/Updates
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Filgrastim Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. Novartis AG Filgrastim Injection Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Filgrastim Injection Distributors List
Table 98. Filgrastim Injection Customers List
Table 99. Filgrastim Injection Market Trends
Table 100. Filgrastim Injection Market Drivers
Table 101. Filgrastim Injection Market Challenges
Table 102. Filgrastim Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Filgrastim Injection
Figure 2. Global Filgrastim Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Filgrastim Injection Market Share by Type in 2023 & 2030
Figure 4. 300mcg/mL (vial) Product Picture
Figure 5. 480mcg/1.6 mL (vial) Product Picture
Figure 6. 300mcg/0.5mL (Prefilled Syringe) Product Picture
Figure 7. 480mcg/0.8mL (Prefilled Syringe) Product Picture
Figure 8. Global Filgrastim Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Filgrastim Injection Market Share by Application in 2023 & 2030
Figure 10. Adult Use
Figure 11. Pediatric Use
Figure 12. Geriatric Use
Figure 13. Global Filgrastim Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Filgrastim Injection Market Size (2019-2030) & (US$ Million)
Figure 15. Global Filgrastim Injection Sales (2019-2030) & (KL)
Figure 16. Global Filgrastim Injection Average Price (US$/L) & (2019-2030)
Figure 17. Filgrastim Injection Report Years Considered
Figure 18. Filgrastim Injection Sales Share by Manufacturers in 2023
Figure 19. Global Filgrastim Injection Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Filgrastim Injection Players: Market Share by Revenue in 2023
Figure 21. Filgrastim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Filgrastim Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Filgrastim Injection Sales Market Share by Country (2019-2030)
Figure 24. North America Filgrastim Injection Revenue Market Share by Country (2019-2030)
Figure 25. United States Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Filgrastim Injection Sales Market Share by Country (2019-2030)
Figure 28. Europe Filgrastim Injection Revenue Market Share by Country (2019-2030)
Figure 29. Germany Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Filgrastim Injection Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Filgrastim Injection Revenue Market Share by Region (2019-2030)
Figure 36. China Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Filgrastim Injection Sales Market Share by Country (2019-2030)
Figure 46. Latin America Filgrastim Injection Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Filgrastim Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Filgrastim Injection by Type (2019-2030)
Figure 56. Global Revenue Market Share of Filgrastim Injection by Type (2019-2030)
Figure 57. Global Filgrastim Injection Price (US$/L) by Type (2019-2030)
Figure 58. Global Sales Market Share of Filgrastim Injection by Application (2019-2030)
Figure 59. Global Revenue Market Share of Filgrastim Injection by Application (2019-2030)
Figure 60. Global Filgrastim Injection Price (US$/L) by Application (2019-2030)
Figure 61. Filgrastim Injection Value Chain
Figure 62. Filgrastim Injection Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
